BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA

  March 17, 2026

   · 

  4 min read
• Press Releases

  Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

  March 17, 2026

   · 

  9 min read
• Press Releases

  Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026

  March 17, 2026

   · 

  4 min read
• Press Releases

  iDEL Therapeutics Launches with €9 Million Seed Financing Led by BiomedVC to Advance Oncology Pipeline Based on Direct Cytosolic Transfer Technology

  March 17, 2026

   · 

  5 min read
• Press Releases

  Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 17, 2026

  March 17, 2026

   · 

  1 min read
• Press Releases

  Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform

  March 17, 2026

   · 

  2 min read
• 

  Legal

  Kennedy’s Vaccine Policy Overhaul Stymied by Federal Judge

  A Massachusetts judge called Kennedy’s efforts to reform the CDC’s vaccines advisory panel a “procedural failure,” adding that the new committee members do not “comport with governing law.”

  March 17, 2026

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Deals

  Astellas Divorces CytomX Despite Positive Phase 1 Data for Antibody Platform

  Astellas Pharma and CytomX Therapeutics first partnered up in March 2020. For $80 million upfront, the Japanese pharma gained access to the biotech’s Probody platform to generate masked antibody therapies for cancer.

  March 17, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

  March 17, 2026

   · 

  3 min read
• Press Releases

  Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

  March 17, 2026

   · 

  7 min read